Cargando…

Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)

INTRODUCTION: There was a growing need for practical guidelines for the most common OIs in Germany and Austria under consideration of the local epidemiological conditions. MATERIALS AND METHODS: The German and Austrian AIDS societies developed these guidelines between March 2010 and November 2011. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Thoden, J., Potthoff, A., Bogner, J. R., Brockmeyer, N. H., Esser, S., Grabmeier-Pfistershammer, K., Haas, B., Hahn, K., Härter, G., Hartmann, M., Herzmann, C., Hutterer, J., Jordan, A. R., Lange, C., Mauss, S., Meyer-Olson, D., Mosthaf, F., Oette, M., Reuter, S., Rieger, A., Rosenkranz, T., Ruhnke, M., Schaaf, B., Schwarze, S., Stellbrink, H. J., Stocker, H., Stoehr, A., Stoll, M., Träder, C., Vogel, M., Wagner, D., Wyen, C., Hoffmann, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776256/
https://www.ncbi.nlm.nih.gov/pubmed/24037688
http://dx.doi.org/10.1007/s15010-013-0504-1
_version_ 1782477461483683840
author Thoden, J.
Potthoff, A.
Bogner, J. R.
Brockmeyer, N. H.
Esser, S.
Grabmeier-Pfistershammer, K.
Haas, B.
Hahn, K.
Härter, G.
Hartmann, M.
Herzmann, C.
Hutterer, J.
Jordan, A. R.
Lange, C.
Mauss, S.
Meyer-Olson, D.
Mosthaf, F.
Oette, M.
Reuter, S.
Rieger, A.
Rosenkranz, T.
Ruhnke, M.
Schaaf, B.
Schwarze, S.
Stellbrink, H. J.
Stocker, H.
Stoehr, A.
Stoll, M.
Träder, C.
Vogel, M.
Wagner, D.
Wyen, C.
Hoffmann, C.
author_facet Thoden, J.
Potthoff, A.
Bogner, J. R.
Brockmeyer, N. H.
Esser, S.
Grabmeier-Pfistershammer, K.
Haas, B.
Hahn, K.
Härter, G.
Hartmann, M.
Herzmann, C.
Hutterer, J.
Jordan, A. R.
Lange, C.
Mauss, S.
Meyer-Olson, D.
Mosthaf, F.
Oette, M.
Reuter, S.
Rieger, A.
Rosenkranz, T.
Ruhnke, M.
Schaaf, B.
Schwarze, S.
Stellbrink, H. J.
Stocker, H.
Stoehr, A.
Stoll, M.
Träder, C.
Vogel, M.
Wagner, D.
Wyen, C.
Hoffmann, C.
author_sort Thoden, J.
collection PubMed
description INTRODUCTION: There was a growing need for practical guidelines for the most common OIs in Germany and Austria under consideration of the local epidemiological conditions. MATERIALS AND METHODS: The German and Austrian AIDS societies developed these guidelines between March 2010 and November 2011. A structured Medline research was performed for 12 diseases, namely Immune reconstitution inflammatory syndrome, Pneumocystis jiroveci pneumonia, cerebral toxoplasmosis, cytomegalovirus manifestations, candidiasis, herpes simplex virus infections, varizella zoster virus infections, progressive multifocal leucencephalopathy, cryptosporidiosis, cryptococcosis, nontuberculosis mycobacteria infections and tuberculosis. Due to the lack of evidence by randomized controlled trials, part of the guidelines reflects expert opinions. The German version was accepted by the German and Austrian AIDS Societies and was previously published by the Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF; German Association of the Scientific Medical Societies). CONCLUSION: The review presented here is a translation of a short version of the German–Austrian Guidelines of opportunistic infections in HIV patients. These guidelines are well-accepted in a clinical setting in both Germany and Austria. They lead to a similar treatment of a heterogeneous group of patients in these countries.
format Online
Article
Text
id pubmed-3776256
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-37762562013-09-20 Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066) Thoden, J. Potthoff, A. Bogner, J. R. Brockmeyer, N. H. Esser, S. Grabmeier-Pfistershammer, K. Haas, B. Hahn, K. Härter, G. Hartmann, M. Herzmann, C. Hutterer, J. Jordan, A. R. Lange, C. Mauss, S. Meyer-Olson, D. Mosthaf, F. Oette, M. Reuter, S. Rieger, A. Rosenkranz, T. Ruhnke, M. Schaaf, B. Schwarze, S. Stellbrink, H. J. Stocker, H. Stoehr, A. Stoll, M. Träder, C. Vogel, M. Wagner, D. Wyen, C. Hoffmann, C. Infection Guideline INTRODUCTION: There was a growing need for practical guidelines for the most common OIs in Germany and Austria under consideration of the local epidemiological conditions. MATERIALS AND METHODS: The German and Austrian AIDS societies developed these guidelines between March 2010 and November 2011. A structured Medline research was performed for 12 diseases, namely Immune reconstitution inflammatory syndrome, Pneumocystis jiroveci pneumonia, cerebral toxoplasmosis, cytomegalovirus manifestations, candidiasis, herpes simplex virus infections, varizella zoster virus infections, progressive multifocal leucencephalopathy, cryptosporidiosis, cryptococcosis, nontuberculosis mycobacteria infections and tuberculosis. Due to the lack of evidence by randomized controlled trials, part of the guidelines reflects expert opinions. The German version was accepted by the German and Austrian AIDS Societies and was previously published by the Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF; German Association of the Scientific Medical Societies). CONCLUSION: The review presented here is a translation of a short version of the German–Austrian Guidelines of opportunistic infections in HIV patients. These guidelines are well-accepted in a clinical setting in both Germany and Austria. They lead to a similar treatment of a heterogeneous group of patients in these countries. Springer Berlin Heidelberg 2013-09-14 2013 /pmc/articles/PMC3776256/ /pubmed/24037688 http://dx.doi.org/10.1007/s15010-013-0504-1 Text en © The Author(s) 2013 Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Guideline
Thoden, J.
Potthoff, A.
Bogner, J. R.
Brockmeyer, N. H.
Esser, S.
Grabmeier-Pfistershammer, K.
Haas, B.
Hahn, K.
Härter, G.
Hartmann, M.
Herzmann, C.
Hutterer, J.
Jordan, A. R.
Lange, C.
Mauss, S.
Meyer-Olson, D.
Mosthaf, F.
Oette, M.
Reuter, S.
Rieger, A.
Rosenkranz, T.
Ruhnke, M.
Schaaf, B.
Schwarze, S.
Stellbrink, H. J.
Stocker, H.
Stoehr, A.
Stoll, M.
Träder, C.
Vogel, M.
Wagner, D.
Wyen, C.
Hoffmann, C.
Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)
title Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)
title_full Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)
title_fullStr Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)
title_full_unstemmed Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)
title_short Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)
title_sort therapy and prophylaxis of opportunistic infections in hiv-infected patients: a guideline by the german and austrian aids societies (daig/öag) (awmf 055/066)
topic Guideline
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776256/
https://www.ncbi.nlm.nih.gov/pubmed/24037688
http://dx.doi.org/10.1007/s15010-013-0504-1
work_keys_str_mv AT thodenj therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT potthoffa therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT bognerjr therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT brockmeyernh therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT essers therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT grabmeierpfistershammerk therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT haasb therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT hahnk therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT harterg therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT hartmannm therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT herzmannc therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT huttererj therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT jordanar therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT langec therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT mausss therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT meyerolsond therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT mosthaff therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT oettem therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT reuters therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT riegera therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT rosenkranzt therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT ruhnkem therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT schaafb therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT schwarzes therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT stellbrinkhj therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT stockerh therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT stoehra therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT stollm therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT traderc therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT vogelm therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT wagnerd therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT wyenc therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066
AT hoffmannc therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066